Myelodysplastic Syndrome
Myelodysplastic syndrome not treated by thalidomide therapy at current dose schedule
Published in Cancer Weekly, October 31st, 2006
According to a study from the United States, "Thalidomide has shown promise for the treatment of patients with myelodysplastic syndrome. The current prospective multicenter study examined the efficacy and toxicity of thalidomide in adult patients with myelodysplastic syndrome."
"Using the International Prognostic Scoring System (IPSS), patients were stratified into 2 groups: favorable (IPSS score, 0-1.0) or unfavorable (IPSS score, 1.53.5)," explained A. Morenoaspitia and colleagues, Mayo Clinic. "Seventy-two patients (42 of whom were favorable and 30 of...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2006-10-31)
More Articles from Cancer Weekly
- Bladder Cancer
Risk of bladder cancer recurrence after radical cystectomy predicted by postoperative nomogram - Esophageal Cancer
Esophageal adenocarcinoma risk linked to XPD 751Gln allele - Osteosarcoma
Primary osteosarcoma in patients older than 40 years of age related to poorer prognosis - Prostate Cancer
Prostate cancer risk lowered by dietary isoflavones due to gut-formed isoflavone metabolites - Cancer Gene Therapy
Chinese University of Hong Kong, Department of Surgery publishes research in cancer gene therapy - Cancer Gene Therapy
Data on cancer gene therapy described by researchers at Huazhong University of Science and Technology, Department of Immunology - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
